⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
AMC6156
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-03 — A Study of AMC6156 in People With Sarcopenia: Registered 12-week randomized placebo-controlled trial in older adults with sarcopenia testing daily AMC6156 for safety plus physical function and strength endpoints; protocol/aims only, no efficacy readout yet. [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
A Study of AMC6156 in People With Sarcopenia
03-aug-2026
novelty 3
per-area 3
strengthens